The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Axial Capital Master, L.p. since 2011.
The trader's CIK number is 1521096.
At the time of the last reporting, Axial Capital Master, L.p. was the Officer of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF).
Also see all insider trading activities at Novelion Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | QLTI | 0 | $0 | 7,563,053 | $26,251,356 | 0 | $0 |
| 2013 | QLTI | 0 | $0 | 288,890 | $1,268,227 | 0 | $0 |
| 2010 | QLTI | 2,489,612 | $17,300,952 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-16 | QLTI | Sale | 7,563,053 | 3.47 | 26,251,356 |
| 2013-07-01 | QLTI | Sale | 288,890 | 4.39 | 1,268,227 |
| 2010-11-08 | QLTI | Buy | 3,667 | 5.63 | 20,645 |
| 2011-08-30 | QLTI | Buy | 271,702 | 7.24 | 1,967,122 |
| 2010-11-11 | QLTI | Buy | 61,492 | 5.72 | 351,734 |
| 2011-08-29 | QLTI | Buy | 1,725,000 | 7.25 | 12,506,250 |
| 2010-07-30 | QLTI | Buy | 37,226 | 5.75 | 214,049 |
| 2010-08-26 | QLTI | Buy | 42,571 | 5.70 | 242,654 |
| 2010-08-27 | QLTI | Buy | 42,571 | 5.81 | 247,337 |
| 2010-08-30 | QLTI | Buy | 6,301 | 5.73 | 36,104 |
| 2010-10-29 | QLTI | Buy | 55,471 | 5.65 | 313,411 |
| 2010-08-31 | QLTI | Buy | 60,506 | 5.78 | 349,724 |
| 2010-09-01 | QLTI | Buy | 5,318 | 5.76 | 30,631 |
| 2010-11-01 | QLTI | Buy | 55,471 | 5.73 | 317,848 |
| 2010-11-02 | QLTI | Buy | 34,958 | 5.81 | 203,105 |
| 2010-08-11 | QLTI | Buy | 85,141 | 5.73 | 487,857 |
| 2010-11-03 | QLTI | Buy | 2,217 | 5.63 | 12,481 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Axial Capital Master, L.p. (Officer of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.